Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine

Pfizer Inc and German partner BioNTech SA have filed for a full approval for their COVID-19 vaccine, which is now authorized only for emergency use, the drugmakers said on Friday.

A nod by the U.S. Food and Drug Administration will make it the first approved COVID-19 shot and likely help ease hesitancy by raising confidence in the vaccine as an approval will be backed by longer-term data.